Achelois BioPharma
Pre-clinicalAchelois trains patients' T-cell guardians using their own tumor cells—building bespoke T-cell therapies without target or drug discovery. This approach enables a faster, more natural, and potentially more effective path to durable therapies for cancer patients.
Founded
2020
Focus
Viral Technology
About
Achelois trains patients' T-cell guardians using their own tumor cells—building bespoke T-cell therapies without target or drug discovery. This approach enables a faster, more natural, and potentially more effective path to durable therapies for cancer patients.
Funding History
1Total raised: $5M
Seed$5MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile